Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Enhancing Production of Bio-Isoprene Using Hybrid MVA Pathway and Isoprene Synthase in E. coli

  • Jianming Yang,

    Affiliation Biomaterials Center, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, China

  • Mo Xian ,

    Affiliation Biomaterials Center, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, China

  • Sizheng Su,

    Affiliation Department of Biochemistry, Beijing Risun Chemical Technologies Institute, China Risun Coal Chemicals Group Limited, Beijing, China

  • Guang Zhao,

    Affiliation Biomaterials Center, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, China

  • Qingjuan Nie,

    Affiliation College English Office, Foreign Languages School, Qingdao Agricultural University, Qingdao, China

  • Xinglin Jiang,

    Affiliation Biomaterials Center, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, China

  • Yanning Zheng,

    Affiliation Biomaterials Center, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, China

  • Wei Liu

    Affiliation Biomaterials Center, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, China

Enhancing Production of Bio-Isoprene Using Hybrid MVA Pathway and Isoprene Synthase in E. coli

  • Jianming Yang, 
  • Mo Xian, 
  • Sizheng Su, 
  • Guang Zhao, 
  • Qingjuan Nie, 
  • Xinglin Jiang, 
  • Yanning Zheng, 
  • Wei Liu


The depleting petroleum reserve, increasingly severe energy crisis, and global climate change are reigniting enthusiasm for seeking sustainable technologies to replace petroleum as a source of fuel and chemicals. In this paper, the efficiency of the MVA pathway on isoprene production has been improved as follows: firstly, in order to increase MVA production, the source of the “upper pathway” which contains HMG-CoA synthase, acetyl-CoA acetyltransferase and HMG-CoA reductase to covert acetyl-CoA into MVA has been changed from Saccharomyces cerevisiae to Enterococcus faecalis; secondly, to further enhance the production of MVA and isoprene, a alanine 110 of the mvaS gene has been mutated to a glycine. The final genetic strain YJM25 containing the optimized MVA pathway and isoprene synthase from Populus alba can accumulate isoprene up to 6.3 g/L after 40 h of fed-batch cultivation.


Isoprene (2-methyl-1,3-butadiene) was firstly discovered as a cell metabolite in the mid-1950s by Sanadze.[1], [2]. It functions as a thermoprotectant of plant membranes or as an antioxidant [3], [4], or may have a signaling function, altering the flowering time in some plants [5]. As an important platform chemical, isoprene has been used in industrial production of synthetic rubber for tires and coatings [6] or aviation fuel [7].

Isoprene is the progenitor of the isoprenoid family of compounds[8]. Many commercially relevant isoprenoids exist in nature in small quantity and the yield produced from their natural organisms remains rather low. The depletion of fossil sources and the structural complexity of isoprenoids make it difficult or costly to produce isoprenoids by means of chemical synthesis. Isoprene is no exception since it is produced entirely from petrochemical sources through chemical synthesis method [9], [10], [11].

Compared with conventional means, microbial synthesis of isoprene by fermentation should become a promising and attractive route mainly for environmental production, renewable resources, sustainable development[12]. Additionally, isoprene could be collected from the gas phase of the fermentor, eliminating the need for distillation. All isoprenoids are biosynthesized from the same basic units, isopentenyl diphosphate (pyrophosphate IPP), and its isomer dimethylallyl diphosphate (DMAPP), which are synthesized from two different pathways including methylerythritol 4-phosphate (MEP) pathway and mevalonate (MVA) pathway (Fig.1) [13]. MVA pathway mainly exists in eukaryotes, archaebacteria, and cytosols of higher plants, while the MEP pathway is used by many eubacteria, green algae, and chloroplasts of higher plant [14], [15]. MVA pathway has been studied extensively for producing isoprenoids. The introduction of heterologous MVA pathway genes into E. coli has been reported to improve the productivity of carotenoids or sesquiterpenes that are synthesized from DMAPP[16], [17], [18], [19], [20], [21], [22].

Figure 1. Production of isoprene via the MVA pathways used in this study.

Gene symbols and the enzymes they encode (all genes marked with white arrows were isolated from S. cerevisiae, the gene marked with light gray arrows derived from P. alba and all genes marked with gray arrows were from Enterococcus faecalis). MVA pathway: ERG10, acetoacetyl-CoA thiolase; ERG13, HMG-CoA synthase; tHMGR, truncated HMG-CoA reductase; MvaE, acetyl-CoA acetyltransferase/HMG-CoA reductase; MvaS, HMG-CoA synthase; ERG12, mevalonate kinase; ERG8, phosphomevalonate kinase; ERG19, mevalonate pyrophosphate decarboxylase; IDI1, IPP isomerase; ispSPa, P. alba isoprene synthase was optimized to the preferred codon usage of E. coli. Pathway intermediates. MVA pathway: A-CoA, acetyl-CoA; AA-CoA, acetoacetyl-CoA; HMG-CoA, hydroxymethylglutaryl-CoA; Mev-P, mevalonate 5-phosphate; Mev-PP, mevalonate pyrophosphate. IPP, isopentenyl pyrophosphate; DMAPP, dimethylallyl pyrophosphate.

Although MVA pathway has been studied comprehensively, the methylerythritol phosphate (MEP) pathway was merely discovered in the early 1990s by labeling experiments in bacteria and plants[23], [24], and till 2001 the genes of whole MEP pathway has been completely characterized [25]. This biosynthetic pathway, made up of seven enzymatic steps, begins with the condensation of pyruvate and glyceraldehyde-3-phosphate to form 1-deoxy-D-xylulose 5-phosphate (DXP) and ends with the formation of the isoprenoid precursors isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) [26], [27]. In spite of great efforts taken in isoprenoids production using MEP pathway[28], [29], [30], this approach still remains ineffective due to regulation mechanisms present in the native host[18].

In this paper, based on our previous experiments, the efficiency of the MVA pathway on isoprene production has largely been improved as follows: firstly, in order to increase MVA production, the source of the “upper pathway” which contains HMG-CoA synthase, acetyl-CoA acetyltransferase and HMG-CoA reductase to covert acetyl-CoA into MVA has been changed from Saccharomyces cerevisiae to Enterococcus faecalis; secondly, to further enhance the production of MVA and isoprene, a alanine 110 of the mvaS gene has been mutated to a glycine. The final genetic strain YJM25 containing the optimized MVA pathway and isoprene synthase from P. alba can accumulate isoprene up to 6.3 g/L after 40 h of fed-batch cultivation, which is approximately a 12-fold increase in isoprene production compared with the previous data [25].

Materials and Methods

Bacterial Strains, Plasmids, and Growth Conditions

All Strains and plasmids used in this study are listed in Table 1. E. coli strains were grown in LB medium. For MVA or isoprene production, recombinant strains were cultured in shake-flask or fed-batch fermentation with the medium containing glucose 20 g/l, K2HPO4 9.8 g/l, beef extract 5 g/l, ferric ammonium citrate 0.3 g/l, citric acid monohydrate 2.1 g/l, MgSO4 0.06 g/l and 1 ml trace element solution which includes (NH4)6 Mo7O24·4H2O 0.37 g/l, ZnSO4·7 H2O 0.29 g/l, H3BO4 2.47 g/l, CuSO4·5H2O 0.25 g/l, and MnCl2·4H2O 1.58 g/l. If necessary, appropriate antibiotics were added to the culture medium at the following concentration: ampicillin (Amp, 100 µg/ml), kanamycin (Kan, 50 µg/ml), and chloramphenicol (Cm, 34 µg/ml).

Table 1. Strains, plasmids and Oligonucleotide primers used in this study.

Plasmid Construction

Standard DNA manipulations were carried out as previously described by Sambrook et al. [31]. Polymerase chain reaction (PCR) was performed using Pfu DNA polymerase (TaKaRa, Dalian, China) according to the manufacturer’s instruction.

Construction of Plasmid for Upper pathway of MVA

The mvaS (HMG-CoA synthase, GenBank No. AAG02439) and mvaE (acetyl-CoA acetyltransferase/HMG-CoA reductase, GenBank No. AAG02438) genes from E. faecalis were chemically synthesized by Genray Company with plasmid pGH as vector (named pGH/mvaS, pGH/mvaE). The mvaE was obtained by PCR using the primers mvaE-F (5′-CATGCCATGGAGGAGGTAAAAAAACATGAAAACAGTAGTTATTATTGATGC-3′) and mvaE-R (5′-CGCGGATCCTTATTGTTTTCTTAAATCATTTAAAATAG-3′) and pGH/mvaE as a template. The isolated mvaE gene fragment was excised using NcoI and BamHI, followed by insertion into the corresponding sites of pACYCDuet-1 or pYJM8 to create pYJM15 and pYJM18 respectively. The mvaS gene was obtained by PCR using the primers mvaS-F (5′-CCAGAGCTCAGGAGGTAAAAAAACATGACAATTGG GATTGATAAAATTA-3′) and mvaS-R (5′-CAACTGCAGTTAGTTTCGATAAGAGCGAA CG-3′) and pGH/mvaS as a template. The product of mvaS was introduced behind the mvaE gene of pYJM15 or pYJM18 after restriction with SacI and PstI to create pYJM16 (Fig.2A) and pYJM20 (Fig.2C).

Construction of Plasmid for Lower Pathway of MVA

Plasmid pYJM14 was constructed on pTrcHis2B by introducing the ERG8, ERG12, ERG19 and IDI1 from S. cerevisiae. The four genes were ligated into the plasmid pTrcHis2B using the method established in our lab [25], [32] as follows: successive substrate fragments that designed to have long overlaps with each other were mixed, denatured and annealed. Then a circle plasmid can form and be ready for transformation. The plasmid containing four genes (ERG12, ERG8, ERG19 and IDI1) was named pYJM14. The correct insertions of these genes into vectors were confirmed by PCR, restriction digestion and subsequent sequencing.

Mutation of mvaS Gene from Enterococcus Faecalis

The mutation PCR procedure was performed according to the instruction of Fast Mutagenesis System purchased from TransGen Biotech (Beijing, China). Mutagenesis mixtures contained 10×EasyPfu polymerase buffer 2.5 µl, 200 µM dNTPs, 1 ng/ul template, 500 nM each primer, and 1 µl EasyPfu DNA polymerase. The mutated mvaS gene as described by[33] (mvaSMT, A110G) was obtained by PCR using the primers mvaSMT−F (mutation underlined, 5′-CTCTTTCGAAATCAAGGAAGGTTGTTACGGAGC-3′) and mvaSMT−R (5′-CTTCCTTGATTTCGAAAGAGCGAGCGAAAG-3′) and pGH/mvaS as a template. The product of mvaSMT was cloned into the plasmid pYJM15 or pYJM18 behind the mvaE gene after restriction with SacI and PstI to create pYJM17 (Fig.2B) and pYJM21 (Fig.2D) respectively. The pYJM17 and pYJM21 were transformed into the BL21(DE3) competent cell for expression.

MVA Quantification by Gas Chromatography (GC)

The mevalonate produced by the engineered strains was quantitatively analyzed by GC-FID as described previously [34]. The E. coli strain was inoculated in 50 ml fermentation medium containing 34 µg/ml Cm resistance and incubated at 37°C and 180 rpm. When OD600 of the bacterial culture reached 0.6, the culture cells were induced by IPTG at a final concentration of 0.5 mM for 24 h. After fermentation broth was centrifuged for 10 min at 12000 rpm at room temperature, the supernatant was adjusted to pH 2.0 with 3 M HCl and incubated at 45°C for 1 h to convert mevalonate to mevalonic acid lactone. Then this solution was saturated with Na2SO4, and extracted with ethyl acetate. The ethyl acetate phase was transferred to a clean glass vial and dried by vacuum distillation. The residues were re-dissolved in 1 ml of ethyl acetate and analyzed by GC.

GC analysis was performed on an Agilent 7890A equipped with a flame ionization detector (FID) and a HP-AL/S column (25 m×320 µm×8 µm). N2 was used as carrier gas with a linear velocity of 1 ml/min. The column temperature profile was 75°C for 0.5 min, 25°C/min to 150°C, 15°C/min to 200°C, 30°C/min to 250°C, and 250°C for 5 min. The product was characterized by direct comparison with an authentic standard (Sigma-Aldrich, USA). The peak area was converted to MVA concentration by comparing with a standard curve plotted with a set of known concentration of MVA.

Shake-flask Cultures

Shake-flask experiments were carried out in triplicate series of 600 ml sealed shake flasks containing 50 ml fermentation medium as described above plus 34 µg/ml Cm and 100 µg/ml Amp. E. coli strains were inoculated to the culture broth and incubated in a gyratory shaker incubator at 37°C and 180 rpm. When OD600 reached 0.6, IPTG was added to final concentration of 0.5 mM, and culture was further incubated at 30°C for 24 h. Then 1 ml gas sample from the headspace of the sealed cultures was analyzed as described earlier [35] using a GC (Agilent 7890A, America) equipped with a flame ionization detector (FID) and a HP-AL/S column (25 m×320 µm×8 µm). To identify bacterial isoprene production, peak retention times and mass spectra were compared with that of standard. Concentrations of isoprene produced by bacterial cells were calculated by converting GC peak area to mg of isoprene via a calibration curve. Isoprene standard (TCI-EP, Tokyo, Japan) of various concentrations was added to 600 ml fermentation medium to make a calibration curve.

Fed-batch Fermentation

The strain was grown overnight at 37°C in 100 ml of M9 minimal media (containing K2HPO4 1 g, Na2HPO4·12H2O 15.3 g, KH2PO4 3 g, NH4Cl 1 g; NaCl 0.5 g, MgSO4 0.5 mmol in 1 L with glucose (20 g/L) as the primary carbon source). These cultures were used to inoculate a 5-L fermentor (BIOSTAT Bplus MO5L, Sartorius, Germany) containing 3 L fermentation medium. The temperature was controlled at 30°C; the pH was maintained at 7.0 via automated addition of ammonia, and Antifoam 204 was used to prohibit foam development. The stirring speed was first set at 400 rpm and then associated with the dissolved oxygen (DO) to maintain a DO concentration of 20% saturation. The expression of plasmid-borne exogenous gene(s) for isoprene production was initiated at an OD600 of 12 by adding IPTG to the final concentration of 0.5 mM and inducer was added every 8 h. During the course of fermentation, the residual glucose was measured using a glucose analyzer (SBA-40D, China) and maintained below 0.5 g/l by feeding solution containing 800 g/L of glucose at appropriate rates. Then isoprene accumulation was measured every 15 min by GC as described [35]. At the same time, the growth of the bacterial culture was determined by measuring the OD600 with a spectrophotometer (Cary 50 UV-Vis, Varian).

Results and Discussion

Characterization of the Rate-limiting Step of MVA Pathway

In our previous work, a novel pathway for production of isoprene was established by assembling the whole MVA pathway derived from S. cerevisiae and isoprene synthase (IspS) from Populus alba in the E. coli BL21(DE3) strain. The final engineered strain YJM13 harboring the MVA pathway and ispSPa gene could accumulate isoprene up to 2.48 mg/L and 532 mg/L under the flask and fed-batch fermentation conditions, respectively [25]. However, the yield of isoprene by the engineered strain YJM13 is too low to meet the demand for industrial application.

The low yield of isoprene might be primarily attributed to the existing of rate-limiting step of MVA pathway. In the previous study, the whole MVA pathway was divided into two parts and studied respectively: the “upper pathway”, which catalyzed the acetyl-CoA to MVA; the “lower pathway”, which converted MVA into DMAPP, and then was catalyzed by isoprene synthase into isoprene.

As for the study of the efficiency of “lower pathway”, the plasmids pYJM14 and pYJM8 were simultaneously transformed into the E. coli strain. To determine the extent to which isoprene production could be enhanced with increased availability of MVA, different concentrations of MVA were added to the culture broth. The maximum isoprene productions of 57, 118, 213 mg/L were obtained with the addition of 2.5 mM, 5 mM and 10 mM MVA, respectively. The cell growth has not been influenced significantly by the MVA additions (Fig. 3). The results showed that the increased isoprene productivity was in proportion to the content of mevalonate added. The maximum isoprene production of 213 mg/L was obtained with 10 mM mevalonate addition under flask condition. The results implied that the “lower pathway” was very efficient. Meanwhile, the functionality of the heterologous “upper pathway” was also under test. The results showed that overexpression of the synthetic operon of the “upper pathway” could only give a very low yield of MVA (0.026 mg/L). Based on the above-mentioned data, a conclusion could be reached that the “upper pathway” is the rate- limiting step of the whole MVA pathway.

Figure 3. Isoprene production of Strain YJM12.

The strain was cultured supplemented with different concentrations of mevalonate under flask conditions. The experiment was done in triplicate.

Evaluation of Upper Pathway of MVA from Different Origins

To eliminate the limitation of upper pathway of MVA, alteration of the origins of the “upper pathway” of MVA might be a promising way. In the previous report, the mass production of mevalonate of 47 g/L was achieved by fed-batch culture of recombinant E. coli harboring mvaE and mvaS genes of E. faecalis [36]. Yoon also demonstrated that the mvaE and mvaS genes of E. faecalis were the most efficient for mevalonate production among the top MVA portions used in E. coli [22]. Therefore, the engineered strain YJM16 containing mvaS and mvaE gene from E. faecalis instead of “upper pathway” from S. cerevisiae was constructed in this study. The strain YJM16 was inoculated in 50 ml fermentation medium and incubated at 37°C. When OD600 of the bacterial culture reached 0.6, IPTG was added to a final concentration of 0.5 mM, and the culture was further incubated for 24 h. MVA was isolated from fermentation broth as described method. The strain YJM16 containing the mvaS and mvaE gene from E. faecalis could accumulate MVA up to 1.31 g/L, which was about fifty-fold in contrast to the strain YJM11 containing S. cerevisiae’s upper pathway (0.026 mg/L). Obviously, the upper pathway from E. faecalis proves to be more effective than that from S. cerevisiae.

The Effect of Mutation of mvaS Gene on MVA Production

The mvaS gene encodes the HMG-CoA synthase, the second enzyme in the MVA pathway, which catalyzes three molecules of acetyl-CoA to HMG-CoA and plays a key role in isoprenoid formation in the eukaryotic cytosol and in Gram-positive bacteria [37]. Steussy has reported that the overall reaction rate of the enzyme was increased 140-fold by mutating alanine 110 of HMG-CoA synthase from E. faecalis into a glycine [33]. Hence, a hypothesis would be put forward that the engineered strain with the mutated mvaS gene and mvaE from E. faecalis could further enhance the MVA production.

To verify the effect of mutation of mvaS gene on MVA production, the recombinant strains YJM17 (E. coli harboring mvaSMT & mvaE) and YJM16 (E. coli containing mvaS & mvaE) were cultured in fermentation medium under shake-flask conditions. The amount of MVA accumulated in the culture media from different recombinant strains was calculated according to a standard curve plotted with a set of known concentrations of MVA. MVA concentration of the strain YJM17 reached around 3.1 g/L after being induced by 0.5 mM IPTG for 24 h, about 2.37 times higher than that of the strain YJM16 (1.31 g/L)(Fig. 4). The result demonstrated that A110G mutation of mvaS gene caused an appreciable increase in MVA production.

Figure 4. MVA production by strains with or without mutation of mvaS gene.

The MVA isolated from cultural broth as described in “MVA quantification by gas chromatography (GC)”. The experiment was performed in triplicate.

The Effect of Optimized Upper Pathway on Isoprene Production

To test the function of optimized upper pathway on isoprene production, the plasmid pYJM14 containing the lower pathway from S. cerevisiae was transformed into the strains (E. coli harboring mvaSMT & mvaE, mvaS & mvaE), which formed the recombinant strains YJM21 and YJM20, respectively. Both of the strains YJM21 and YJM20 were inoculated into the medium under the shake-flask conditions and the cultures were induced with 0.5 mM IPTG when the OD600 reached 0.6–0.9. As is shown in Fig. 5, isoprene produced by the strain YJM21 reached 760 mg/L, which was about 1.5 fold to the control strain YJM20 (500 mg/L). The result showed that the optimized upper pathway played an important role in improving the isoprene production.

Figure 5. Comparison of isoprene production from different recombinant strains.

The experiment was conducted under flask conditions in triplicate.

Figure 6. The time course of isoprene production by YJM25.

Isoprene accumulation (▪) and cell growth (Δ) in YJM25, Induction was carried out at an OD600 of 12. Other experiment conditions were described in ‘Fed-batch fermentation’.

Comparison of Isoprene Production in Different E. coli Host Strains

To choose a most efficient host strain for isoprene production, plasmids pYJM20 and pYJM21 were transformed into E. coli host strains JM109 (DE3), BL21 (DE3) and BL21 star (DE3) carrying plasmid pYJM14, respectively. As shown in the Table 2, BL21 star (DE3) produced more isoprene than BL21 (DE3), while the yield of isoprene produced by JM109 (DE3) was the lowest among three strains. Obviously, BL21 star (DE3) was the most suitable host to produce isoprene. No significant difference in cell growth was observed for all these strains.

Table 2. Isoprene production by different E. coli strains harboring pYJM14 and pYJM20 or pYJM14 and pYJM21 under flask conditions.

Fed-batch Culture of Metabolically Engineered E. coli Strains

To further confirm the effectiveness of the optimized MVA pathway on increasing isoprene production, fed-batch cultivation was carried out using the recombinant E. coli BL21(DE3) strain simultaneously harboring plasmids pYJM21 and pYJM14. After depletion of the glucose added initially, glucose (800 g l−1) was fed and the residual glucose was maintained below 0.5 g/l to minimize acetic acid accumulation. As is shown in Fig. 6, isoprene was produced in a growth associated manner in the fed-batch phase to reach maximum concentration of 6.3 g l−1 after 40 h of cultivation. The conversion efficiency of glucose to isoprene in the metabolically engineered strain has attained 7%, reaching 28% of the theoretical limit (25.2%). The theoretical yield was calculated according to the following formula [13]:


Expressing the optimized MVA pathway and isoprene synthase from P. alba resulted in approximately a 12-fold increase in isoprene production compared with our previous data achieved by expression of the MVA pathway from S. cerevisiae and isoprene synthase in the same host strain.

In spite of the great progress for isoprene production made in E. coli, some problems still remained unsolved and were expected to be tackled before commercial production. For instance, the instability of the recombinant strain remains to be a severe problem due to the plasmid instability which in turn restricts the industrial application to a large extent. From metabolic engineering perspective, the stability of strain can be improved by genetic manipulation of chromosome integration technique [38], [39]. From the fermentation process aspect, immobilization of microbial cells may enhance the stability of engineered stain during the process of production [40], [41].


In this paper, the efficiency of the MVA pathway on isoprene production has largely been improved by changing the source of “upper pathway” of MVA synthesis from S. cerevisiae to E. faecalis and mutating the mvaS gene. In the final engineered strain YJM25 (E. coli BL21(DE3)/pYJM21, pYJM14) containing the optimized MVA pathway and isoprene synthase, it can accumulated isoprene up to 6.3 g/L after 40 h fed-batch fermentation. The conversion efficiency of glucose to isoprene (gram to gram) in the metabolically engineered strain has attained 7%, reaching 28% of the theoretical limit. These results proved to be the highest isoprene productivity reported so far [7], [29], [42].

Author Contributions

Conceived and designed the experiments: JY MX. Performed the experiments: JY. Analyzed the data: JY SS XJ YZ. Contributed reagents/materials/analysis tools: JY GZ WL. Wrote the paper: JY. Refined the manuscript: QN.


  1. 1. Sanadze G (1956) Emission of Gaseous Organic Substances from Plants. Repertuar Akademiia Nauk Gruzinskoi SSR 17: 429–433.
  2. 2. Sanadze G (1957) Nature of Gaseous Substances from the Robinia pseudoacacia Leaves. Rep Akad Nauk GruzSSR 19: 83¨ sC86:
  3. 3. Loreto F, Velikova V (2001) Isoprene produced by leaves protects the photosynthetic apparatus against ozone damage, quenches ozone products, and reduces lipid peroxidation of cellular membranes. Plant Physiology 127: 1781.
  4. 4. Peñuelas J, Llusia J, Asensio D, Munné-Bosch S (2005) Linking isoprene with plant thermotolerance, antioxidants and monoterpene emissions. Plant, Cell & Environment 28: 278–286.
  5. 5. Terry G, Stokes N, Hewitt C, Mansfield T (1995) Exposure to isoprene promotes flowering in plants. Journal of experimental botany 46: 1629.
  6. 6. Alianell GA, Derwitsch F, Wells D, Taylor T (2010) Isoprene compositions and methods of use. US2010/0099932 A1:
  7. 7. Lindberg P, Park S, Melis A (2010) Engineering a platform for photosynthetic isoprene production in cyanobacteria, using Synechocystis as the model organism. Metabolic Engineering 12: 70–79.
  8. 8. Sacchettini JC, Poulter CD (1997) Creating isoprenoid diversity. Science 277: 1788.
  9. 9. Reis T (1972) Isoprene production.2. Synthesis based on isobutylene. Chem Process Eng 53: 68–71.
  10. 10. Ushio S (1972) Extract isoprene with DMF. Chem Eng Prog 79: 82–83.
  11. 11. DiGiacomo AA, Maerker JB, Schall JW (1961) Isoprene by Dehydrogenation. Chem Eng Prog 57: 3540.
  12. 12. Clomburg JM, Gonzalez R (2010) Biofuel production in Escherichia coli: the role of metabolic engineering and synthetic biology. Applied microbiology and biotechnology 86: 419–434.
  13. 13. Steinbuchel A (2003) Production of rubber-like polymers by microorganisms. Current Opinion in Microbiology 6: 261–270.
  14. 14. Seemann M, Campos N, Rodriguez-Concepción M, Ibañez E, Duvold T, et al. (2002) Isoprenoid biosynthesis in Escherichia coli via the methylerythritol phosphate pathway: enzymatic conversion of methylerythritol cyclodiphosphate into a phosphorylated derivative of (E)-2-methylbut-2-ene-1, 4-diol. Tetrahedron Letters 43: 1413–1415.
  15. 15. Eroglu E, Melis A (2010) Extracellular terpenoid hydrocarbon extraction and quantitation from the green microalgae Botryococcus braunii var. Showa. Bioresource technology 101: 2359–2366.
  16. 16. Anthony JR, Anthony LC, Nowroozi F, Kwon G, Newman JD, et al. (2009) Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4, 11-diene. Metabolic Engineering 11: 13–19.
  17. 17. Campos N, Rodriguez-Concepcion M, Sauret-Gueto S, Gallego F, Lois L, et al. (2001) Escherichia coli engineered to synthesize isopentenyl diphosphate and dimethylallyl diphosphate from mevalonate: a novel system for the genetic analysis of the 2-C-methyl-d-erythritol 4-phosphate pathway for isoprenoid biosynthesis. Biochemical Journal 353: 59.
  18. 18. Martin VJJ, Pitera DJ, Withers ST, Newman JD, Keasling JD (2003) Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nature biotechnology 21: 796–802.
  19. 19. Newman JD, Marshall J, Chang M, Nowroozi F, Paradise E, et al. (2006) High-level production of amorpha-4, 11-diene in a two-phase partitioning bioreactor of metabolically engineered Escherichia coli. Biotechnology and bioengineering 95: 684–691.
  20. 20. Pitera DJ, Paddon CJ, Newman JD, Keasling JD (2007) Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. Metabolic Engineering 9: 193–207.
  21. 21. Rodriguez-Villalon A, Perez-Gil J, Rodriguez-Concepcion M (2008) Carotenoid accumulation in bacteria with enhanced supply of isoprenoid precursors by upregulation of exogenous or endogenous pathways. Journal of biotechnology 135: 78–84.
  22. 22. Yoon SH, Lee SH, Das A, Ryu HK, Jang HJ, et al. (2009) Combinatorial expression of bacterial whole mevalonate pathway for the production of [beta]-carotene in E. coli. Journal of biotechnology 140: 218–226.
  23. 23. Rohmer M, Knani M, Simonin P, Sutter B, Sahm H (1993) Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate. Biochemical Journal 295: 517.
  24. 24. Schwarz MK (1994) Terpen-Biosynthese in Ginkgo biloba:Eine überraschende Geschichte. PhD Thesis, ETH Zürich, Switzerland.
  25. 25. Rodrı?guez-Concepción M, Boronat A (2002) Elucidation of the methylerythritol phosphate pathway for isoprenoid biosynthesis in bacteria and plastids. A metabolic milestone achieved through genomics. Plant Physiology 130: 1079–1089.
  26. 26. Eisenreich W, Bacher A, Arigoni D, Rohdich F (2004) Biosynthesis of isoprenoids via the non-mevalonate pathway. Cellular and Molecular Life Sciences 61: 1401–1426.
  27. 27. Rodriguez-Concepcion M (2004) The MEP pathway: A new target for the development of herbicides, antibiotics and antimalarial drugs. Current Pharmaceutical Design 10: 2391–2400.
  28. 28. Kim SJ, Kim MD, Choi JH, Kim SY, Ryu YW, et al. (2006) Amplification of 1-deoxy-d-xyluose 5-phosphate (DXP) synthase level increases coenzyme Q 10 production in recombinant Escherichia coli. Applied Microbiology and Biotechnology 72: 982–985.
  29. 29. Xue JF, Ahring BK (2011) Enhancing isoprene production by genetic modification of the DXP pathway in Bacillus subtilis. Applied and environmental microbiology 77: 2399–2405.
  30. 30. Ghimire GP, Lee HC, Sohng JK (2009) Improved Squalene Production via Modulation of the Methylerythritol 4-Phosphate Pathway and Heterologous Expression of Genes from Streptomyces peucetius ATCC 27952 in Escherichia coli. Applied and Environmental Microbiology 75: 7291.
  31. 31. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
  32. 32. Jiang X YJ, Zhang H, Zou H, Wang C (2012) In Vitro Assembly of Multiple DNA Fragments Using Successive Hybridization. PLoS ONE. e30267 p.
  33. 33. Steussy CN, Robison AD, Tetrick AM, Knight JT, Rodwell VW, et al. (2006) A structural limitation on enzyme activity: the case of HMG-CoA synthase. Biochemistry 45: 14407–14414.
  34. 34. Pfleger BF, Pitera DJ, Newman JD, Martin VJJ, Keasling JD (2007) Microbial sensors for small molecules: development of a mevalonate biosensor. Metabolic Engineering 9: 30–38.
  35. 35. Julsing MK, Rijpkema M, Woerdenbag HJ, Quax WJ, Kayser O (2007) Functional analysis of genes involved in the biosynthesis of isoprene in Bacillus subtilis. Applied microbiology and biotechnology 75: 1377–1384.
  36. 36. Tabata K, Hashimoto SI (2004) Production of mevalonate by a metabolically-engineered Escherichia coli. Biotechnology letters 26: 1487–1491.
  37. 37. Steussy CN, Vartia AA, Burgner JW, Sutherlin A, Rodwell VW, et al. (2005) X-ray crystal structures of HMG-CoA synthase from Enterococcus faecalis and a complex with its second substrate/inhibitor acetoacetyl-CoA. Biochemistry 44: 14256–14267.
  38. 38. Kuhlman TE, Cox EC (2010) Site-specific chromosomal integration of large synthetic constructs. Nucleic Acids Research 38: e92.
  39. 39. Chen HT, Lin MS, Hou SY (2008) Multiple-copy-gene integration on chromosome of Escherichia coli for beta-galactosidase production. Korean Journal of Chemical Engineering 25: 1082–1087.
  40. 40. Chen X, Xu Z, Cen P, Wong W (2006) Enhanced plasmid stability and production of hEGF by immobilized recombinant E. coli JM101. Biochemical engineering journal 28: 215–219.
  41. 41. Kilonzo P, Margaritis A, Bergougnou M (2009) Airlift-driven fibrous-bed bioreactor for continuous production of glucoamylase using immobilized recombinant yeast cells. Journal of biotechnology 143: 60–68.
  42. 42. Zhao Y, Yang J, Qin B, Li Y, Sun Y, et al. (2011) Biosynthesis of isoprene in Escherichia coli via methylerythritol phosphate (MEP) pathway. Applied microbiology and biotechnology. pp. 1–8.